PRELUDE CAPITAL MANAGEMENT, LLC - ANIKA THERAPEUTICS INC ownership

ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 168 filers reported holding ANIKA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of ANIKA THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$43,000
-78.3%
1,490
-61.0%
0.00%
-62.5%
Q4 2019$198,000
+20.7%
3,822
-21.4%
0.01%
-27.3%
Q4 2018$164,000
+59.2%
4,865
+51.7%
0.01%
+57.1%
Q2 2018$103,000
-93.1%
3,207
-87.5%
0.01%
-94.8%
Q3 2017$1,491,000
+127.3%
25,700
+93.2%
0.13%
+116.1%
Q2 2017$656,000
+0.6%
13,300
-11.3%
0.06%0.0%
Q1 2017$652,000
+1178.4%
15,000
+1305.8%
0.06%
+1140.0%
Q3 2016$51,000
-73.0%
1,067
-76.8%
0.01%
-80.8%
Q1 2015$189,000
+47.7%
4,600
+66.1%
0.03%
+52.9%
Q2 2014$128,000
+58.0%
2,769
+40.6%
0.02%
+54.5%
Q1 2014$81,0001,9690.01%
Other shareholders
ANIKA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 44,875$2,031,0002.14%
Parian Global Management LP 102,705$4,648,0001.16%
CAPITAL MANAGEMENT CORP /VA 93,035$4,211,0001.15%
Avidity Partners Management LP 731,000$33,085,0001.07%
Sio Capital Management, LLC 65,382$2,959,0000.61%
DIKER MANAGEMENT LLC 21,835$988,0000.50%
Archon Capital Management LLC 48,925$2,214,0000.38%
Caption Management, LLC 362,800$16,420,0000.37%
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC 1,546,260$69,984,0000.20%
Boston Trust Walden Corp 378,167$17,116,0000.18%
View complete list of ANIKA THERAPEUTICS INC shareholders